Hims & Hers app downloads surged 47% in February. Demand for GLP-1 weight-loss drugs is the most likely reason for the growth. But sales of such weight loss drugs are going away soon, and the ...

Hims & Hers Health is up 25% since the beginning of the year, but at $31.50 per share, it is still trading 54.2% below its 52-week high of $68.74 from February 2025.

Telehealth company Hims & Hers (HIMS) saw a major boost in app downloads during February. According to a Top-rated analyst, Craig Hettenbach from Morgan Stanley (MS), third-party data revealed a ...

In this article, we are going to take a look at where Hims & Hers Health, Inc. (NYSE:HIMS) stands against other stocks that outperform the broader market. Imagine choosing a group of stocks that ...

Below is Validea's guru fundamental report for HIMS & HERS HEALTH INC (HIMS). Of the 22 guru strategies we follow, HIMS rates highest using our Small-Cap Growth Investor model based on the ...

Try Now>> See the top stocks recommended by analysts >> Read More on HIMS: Questions or Comments about the article? Write to [email protected] Hims & Hers Health NewsMORE Related Stocks Indices ...

Merritt had to find doctors who were HIMS specialists. HIMS stands for Human Intervention Motivational Study, which was created in the 1970s and helps pilots recover from alcohol and drug abuse.